scispace - formally typeset
D

Delfina Costa

Researcher at University of Genoa

Publications -  31
Citations -  568

Delfina Costa is an academic researcher from University of Genoa. The author has contributed to research in topics: Cancer & Cellular differentiation. The author has an hindex of 11, co-authored 26 publications receiving 399 citations.

Papers
More filters
Journal ArticleDOI

Human Gut-Associated Natural Killer Cells in Health and Disease

TL;DR: This review will analyze the known functions of NK cells in the gut mucosa both in health and disease, focusing on the cross-talk among bowel microenvironment, epithelial barrier integrity, microbiota, and NK cells.
Journal ArticleDOI

Bone turnover in wild type and pleiotrophin-transgenic mice housed for three months in the International Space Station (ISS).

TL;DR: A bone loss during spaceflight in the weight-bearing bones of both strains was revealed, and osteocytes of the Wt mice, but not of Tg mice, acquired a round shape, thus showing for the first time osteocyte space-related morphological alterations in vivo.
Journal ArticleDOI

Altered bone development and turnover in transgenic mice over-expressing lipocalin-2 in bone.

TL;DR: It is found that LCN2 plays a role in bone development and turnover having both a negative effect on bone formation, by affecting growth plate development and interfering with osteoblast differentiation, and a positive effect onBone resorption by enhancing osteoclast compartment.
Journal ArticleDOI

ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing

TL;DR: Aim of the present work was to verify whether inhibition of ADAM10 in HL cells could restore the triggering of NKG2D-dependent anti-lymphoma T cell response, and synthesized the two hydroxamate compounds LT4 and MN8 with selectivity forADAM10 over metalloproteases (MMPs), LT4 showing higher specificity for ADAM 10 over ADAM17.
Journal ArticleDOI

Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.

TL;DR: It is shown that CRC, exposed to Zol, stimulates the expansion of Vδ2 T lymphocytes with effector memory phenotype and antitumor cytotoxic activity, besides sensitizing cancer cells to γδ T cell-mediated cytotoxicity.